Literature DB >> 12699425

CCR4 is an up-regulated chemokine receptor of peripheral blood memory CD4+ T cells in Crohn's disease.

Y Jo1, T Matsumoto, S Yada, K Fujisawa, M Esaki, N Onai, K Matsushima, M Iida.   

Abstract

Several chemokine receptors are expressed selectively on the surface of T cells depending on their polarization. The aim of this study was to characterize chemokine receptor expression in peripheral blood memory T cells in Crohn's disease (CD) and ulcerative colitis (UC), and to correlate the expression with disease activity. Peripheral blood mononuclear cells (PBMCs) were obtained from 24 patients with CD, 30 patients with UC, 24 normal controls and 10 disease controls. PBMCs were stained by anti-CCR3, CCR4, CCR5, CXCR3, CD4, CD8, CD45RO and beta 7 integrin, and the expression of the chemokine receptors were determined by flow cytometry. CCR4 expression on memory T cells was significantly lower in UC than in CD or normal controls, and that of memory CD4+ T and beta 7(high) memory CD4+ T cells was significantly higher in CD than in UC or normal controls. CCR4 expression on memory CD4+ T cells exhibited significant positive correlation with disease activity in CD, and this decreased significantly after treatment. Such a decrease was not found in the disease controls. CCR5 and CXCR3 expression on memory CD8+ T cells was significantly lower in CD than in normal controls. CXCR3 expression on beta 7(high) memory CD4+ T and CXCR3 expression on memory CD8+ T cells were lower in UC than in normal controls. These findings suggest that in peripheral blood memory T cells, chemokine receptor expression is different between CD and UC. Enhancement of CCR4 and suppression of CCR5 and CXCR3 seem to be the characteristic chemokine receptor profile in peripheral blood memory T cells of CD.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12699425      PMCID: PMC1808697          DOI: 10.1046/j.1365-2249.2003.02155.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  40 in total

1.  Chemokine receptor CXCR3 expression in inflammatory bowel disease.

Authors:  Y H Yuan; T ten Hove; F O The; J F Slors; S J van Deventer; A A te Velde
Journal:  Inflamm Bowel Dis       Date:  2001-11       Impact factor: 5.325

2.  Characterization of chemokine receptor expression and cytokine production in circulating CD4+ T cells from patients with atopic dermatitis: up-regulation of C-C chemokine receptor 4 in atopic dermatitis.

Authors:  H Okazaki; M Kakurai; D Hirata; H Sato; T Kamimura; N Onai; K Matsushima; H Nakagawa; S Kano; S Minota
Journal:  Clin Exp Allergy       Date:  2002-08       Impact factor: 5.018

Review 3.  Migration pathways and immunologic memory among T lymphocytes.

Authors:  C R Mackay
Journal:  Semin Immunol       Date:  1992-02       Impact factor: 11.130

4.  An index of disease activity in patients with ulcerative colitis.

Authors:  M Seo; M Okada; T Yao; M Ueki; S Arima; M Okumura
Journal:  Am J Gastroenterol       Date:  1992-08       Impact factor: 10.864

5.  Alpha 4 beta 7 integrin mediates lymphocyte binding to the mucosal vascular addressin MAdCAM-1.

Authors:  C Berlin; E L Berg; M J Briskin; D P Andrew; P J Kilshaw; B Holzmann; I L Weissman; A Hamann; E C Butcher
Journal:  Cell       Date:  1993-07-16       Impact factor: 41.582

Review 6.  Immune events associated with inflammatory bowel disease.

Authors:  C Fiocchi
Journal:  Scand J Gastroenterol Suppl       Date:  1990

7.  Adhesion between epithelial cells and T lymphocytes mediated by E-cadherin and the alpha E beta 7 integrin.

Authors:  K L Cepek; S K Shaw; C M Parker; G J Russell; J S Morrow; D L Rimm; M B Brenner
Journal:  Nature       Date:  1994-11-10       Impact factor: 49.962

8.  Rules of chemokine receptor association with T cell polarization in vivo.

Authors:  C H Kim; L Rott; E J Kunkel; M C Genovese; D P Andrew; L Wu; E C Butcher
Journal:  J Clin Invest       Date:  2001-11       Impact factor: 14.808

9.  Increased CCR4 expression in active systemic lupus erythematosus.

Authors:  K Hase; K Tani; T Shimizu; Y Ohmoto; K Matsushima; S Sone
Journal:  J Leukoc Biol       Date:  2001-11       Impact factor: 4.962

10.  Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study.

Authors:  W R Best; J M Becktel; J W Singleton; F Kern
Journal:  Gastroenterology       Date:  1976-03       Impact factor: 22.682

View more
  3 in total

1.  Increased expression of chemokine receptor CCR3 and its ligands in ulcerative colitis: the role of colonic epithelial cells in in vitro studies.

Authors:  P Manousou; G Kolios; V Valatas; I Drygiannakis; L Bourikas; K Pyrovolaki; I Koutroubakis; H A Papadaki; E Kouroumalis
Journal:  Clin Exp Immunol       Date:  2010-11       Impact factor: 4.330

Review 2.  Nutritional therapy for Crohn's disease in Japan.

Authors:  Toshiyuki Matsui; Toshihiro Sakurai; Tsuneyoshi Yao
Journal:  J Gastroenterol       Date:  2005-03       Impact factor: 7.527

3.  Immune phenotype in children with therapy-naïve remitted and relapsed Crohn's disease.

Authors:  Aron Cseh; Barna Vasarhelyi; Kriszta Molnar; Balazs Szalay; Peter Svec; Andras Treszl; Antal Dezsofi; Peter-Laszlo Lakatos; Andras Arato; Tivadar Tulassay; Gabor Veres
Journal:  World J Gastroenterol       Date:  2010-12-21       Impact factor: 5.742

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.